Search for topics, articles, videos, research, etc...
Hit enter to search or ESC to close
Are you looking for:
MJFF Publications
Donate Now
Access Resources

MJFF Publications
5631 - 5640 of 9016 Results
Title
Year
  • Year
  • 2022
  • 2022
  • 2020
  • 2022
  • 2022
  • 2022
  • 2022
  • 2020
  • 2021
  • 2021
  • Commentary on Long-term Effectiveness of Adjuvant Treatment in Parkinson Disease
    2022
    Summary Details
    RESTRICTED
    Title: Commentary on Long-term Effectiveness of Adjuvant Treatment in Parkinson Disease
    Author(s): Priti Gros, Susan H. Fox, Anthony E. Lang
    Journal Name: JAMA Neurology
    Publisher: American Medical Association (AMA)
    Vol: 79
    Issue #: 7
    Start Page: 726
    End Page: 726
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1001/jamaneurol.2022.1601
    Citation Count: 0
  • Commentary on Long-term Effectiveness of Adjuvant Treatment in Parkinson Disease—Reply
    2022
    Summary Details
    RESTRICTED
    Title: Commentary on Long-term Effectiveness of Adjuvant Treatment in Parkinson Disease—Reply
    Author(s): Richard Gray, Crispin Jenkinson, Carl E Clarke
    Journal Name: JAMA Neurology
    Publisher: American Medical Association (AMA)
    Vol: 79
    Issue #: 7
    Start Page: 726
    End Page: 726
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1001/jamaneurol.2022.1604
    Citation Count: 0
  • Reforming the Process for Deep Brain Stimulation and Neurologic Device Approval in Rare Diseases
    2020
    Summary Details
    RESTRICTED
    Title: Reforming the Process for Deep Brain Stimulation and Neurologic Device Approval in Rare Diseases
    Author(s): Michael S. Okun, James Giordano
    Journal Name: JAMA Neurology
    Publisher: American Medical Association (AMA)
    Vol: 78
    Issue #: 1
    Start Page: 5
    End Page: 5
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1001/jamaneurol.2020.4232
    Citation Count: 3
  • Association of Plasma and Cerebrospinal Fluid Alzheimer Disease Biomarkers With Race and the Role of Genetic Ancestry, Vascular Comorbidities, and Neighborhood Factors
    2022
    Summary Details
    OPEN
    Title: Association of Plasma and Cerebrospinal Fluid Alzheimer Disease Biomarkers With Race and the Role of Genetic Ancestry, Vascular Comorbidities, and Neighborhood Factors
    Author(s): Ihab Hajjar, Zhiyi Yang, Maureen Okafor, Chang Liu, Teresa Waligórska, Felicia C. Goldstein, Leslie M. Shaw
    Journal Name: JAMA Network Open
    Publisher: American Medical Association (AMA)
    Vol: 5
    Issue #: 10
    Start Page: e2235068
    End Page: e2235068
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1001/jamanetworkopen.2022.35068
    Best OA location URL: https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2797044/hajjar_2022_oi_220997_1664303851.08078.pdf
    Citation Count: 99
  • Association of Cerebrospinal Fluid Neurofilament Heavy Protein Levels With Clinical Progression in Patients With Parkinson Disease
    2022
    Summary Details
    OPEN
    Title: Association of Cerebrospinal Fluid Neurofilament Heavy Protein Levels With Clinical Progression in Patients With Parkinson Disease
    Author(s): Linbo Wang, Wei Zhang, Fengtao Liu, Chengjie Mao, Chun‐Feng Liu, Wei Cheng, Jianfeng Feng
    Journal Name: JAMA Network Open
    Publisher: American Medical Association (AMA)
    Vol: 5
    Issue #: 7
    Start Page: e2223821
    End Page: e2223821
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1001/jamanetworkopen.2022.23821
    Best OA location URL: https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2794635/wang_2022_oi_220672_1659467066.66779.pdf
    Citation Count: 13
  • Effect of Urate-Elevating Inosine on Progression of Early Parkinson Disease—Reply
    2022
    Summary Details
    RESTRICTED
    Title: Effect of Urate-Elevating Inosine on Progression of Early Parkinson Disease—Reply
    Author(s): Eric A. Macklin, Alberto Ascherio, Michael A. Schwarzschild
    Journal Name: JAMA
    Publisher: American Medical Association (AMA)
    Vol: 327
    Issue #: 1
    Start Page: 85
    End Page: 85
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1001/jama.2021.21011
    Citation Count: 4
  • Effect of Urate-Elevating Inosine on Progression of Early Parkinson Disease
    2022
    Summary Details
    RESTRICTED
    Title: Effect of Urate-Elevating Inosine on Progression of Early Parkinson Disease
    Author(s): Steven J. Frucht
    Journal Name: JAMA
    Publisher: American Medical Association (AMA)
    Vol: 327
    Issue #: 1
    Start Page: 85
    End Page: 85
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1001/jama.2021.21008
    Citation Count: 5
  • Palliative Care for Persons Living With Parkinson Disease
    2020
    Summary Details
    OPEN
    Title: Palliative Care for Persons Living With Parkinson Disease
    Author(s): Leonard L. Sokol, Benzi M. Kluger
    Journal Name: JAMA
    Publisher: American Medical Association (AMA)
    Vol: 324
    Issue #: 15
    Start Page: 1579
    End Page: 1579
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1001/jama.2020.18333
    Best OA location URL: https://jamanetwork.com/journals/jama/articlepdf/2771904/jama_sokol_2020_pg_200052_1602876114.33828.pdf
    Citation Count: 9
  • Basal Synaptic Transmission and Long-Term Plasticity at CA3-CA1 Synapses Are Unaffected in Young Adult PINK1-Deficient Rats
    2021
    Summary Details
    OPEN
    Title: Basal Synaptic Transmission and Long-Term Plasticity at CA3-CA1 Synapses Are Unaffected in Young Adult PINK1-Deficient Rats
    Author(s): Adeel Memon, Micah E. Bagley, Rose B. Creed, Amy W. Amara, Matthew S. Goldberg, Lori L. McMahon
    Journal Name: Frontiers in Neuroscience
    Publisher: Frontiers Media SA
    Vol: 15
    Issue #:
    Start Page: 655901
    End Page: 655901
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnins.2021.655901
    Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnins.2021.655901/pdf
    Citation Count: 2
  • Dopaminergic Therapy for Motor Symptoms in Early Parkinson Disease Practice Guideline Summary
    2021
    Summary Details
    OPEN
    Title: Dopaminergic Therapy for Motor Symptoms in Early Parkinson Disease Practice Guideline Summary
    Author(s): Tamara Pringsheim, Gregory S. Day, Don B. Smith, Alex Rae-Grant, Nicole Licking, Melissa J. Armstrong, Rob M.A. de Bie, Emmanuel Roze, Janis M. Miyasaki, Robert A. Hauser, Alberto J. Espay, Justin P. Martello, Julie A. Gurwell, Lori Billinghurst, Kelly Sullivan, Michael S. Fitts, Nicholas Cothros, Deborah A. Hall, Miriam Rafferty, Lynn Hagerbrant, Tara Hastings, Mary Dolan O'Brien, Heather Silsbee, Gary Gronseth, Anthony E. Lang, Tamara Pringsheim, Gregory S. Day, DonB. Smith, Alex Rae-Grant, Nicole Licking, Melissa J. Armstrong, Rob M. A. de Bie, Emmanuel Roze, Janis M. Miyasaki, Robert A.Hauser, Alberto J. Espay, Justin P. Martello, Julie Gurwell, Lori Billinghurst, Kelly Sullivan, Michael S. Fitts, Nicholas Cothros, Deborah A. Hall, Miriam Rafferty, Lynn Hagerbrant, Tara Hastings, Mary Dolan O’Brien, Heather Silsbee, Gary Gronseth, Anthony E. Lang
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Vol: 97
    Issue #: 20
    Start Page: 942
    End Page: 957
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000012868
    Best OA location URL: https://n.neurology.org/content/neurology/97/20/942.full.pdf
    Citation Count: 175
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.